Brennan M R Spiegel1, Gil Melmed, Sean Robbins, Eric Esrailian. 1. Department of Medicine, VA Greater Los Angeles Healthcare System, David Geffen School of Medicine at UCLA, Los Angeles, CA 90073, USA. bspiegel@mednet.ucla.edu
Abstract
BACKGROUND AND OBJECTIVES: Health-related quality of life (HRQOL) predicts mortality in ESRD, yet adoption of HRQOL monitoring is not widespread, and regulatory authorities remain predominantly concerned with monitoring traditional biologic parameters. To assist with future efforts to adopt HRQOL monitoring while acknowledging the importance of biomarkers, this study sought to establish which domains of HRQOL are most affected by ESRD and to measure the strength of evidence linking common biomarkers to HRQOL in ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A systematic review was performed to identify studies that measured HRQOL in ESRD. Data were abstracted according to a conceptual model regarding the measurement of HRQOL differences, and HRQOL data were converted to weighted mean effect sizes and correlation coefficients. RESULTS: The impact of ESRD was largest in the Short Form 36 domains of physical functioning (e.g., role-physical, vitality) and smallest in mental functioning (e.g., mental health, role-emotional). Dialysis adequacy, as measured by Kt/V, was a poor correlate for Short Form 36 scores. Similarly, mineral metabolism (e.g., calcium x phosphorous, parathyroid hormone) and inflammatory (e.g., C-reactive protein, TNF) biomarkers had small effect sizes and correlations with HRQOL. In contrast, hematocrit demonstrated small to moderate relationships with mental and physical HRQOL, and nutritional biomarkers (e.g., albumin, creatinine, body mass index) demonstrated moderate to large relationships. CONCLUSIONS: HRQOL in ESRD is most affected in the physical domains, and nutritional biomarkers are most closely associated with these domains. In contrast, Kt/V, mineral metabolism indices, and inflammatory markers are poor HRQOL correlates.
BACKGROUND AND OBJECTIVES: Health-related quality of life (HRQOL) predicts mortality in ESRD, yet adoption of HRQOL monitoring is not widespread, and regulatory authorities remain predominantly concerned with monitoring traditional biologic parameters. To assist with future efforts to adopt HRQOL monitoring while acknowledging the importance of biomarkers, this study sought to establish which domains of HRQOL are most affected by ESRD and to measure the strength of evidence linking common biomarkers to HRQOL in ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A systematic review was performed to identify studies that measured HRQOL in ESRD. Data were abstracted according to a conceptual model regarding the measurement of HRQOL differences, and HRQOL data were converted to weighted mean effect sizes and correlation coefficients. RESULTS: The impact of ESRD was largest in the Short Form 36 domains of physical functioning (e.g., role-physical, vitality) and smallest in mental functioning (e.g., mental health, role-emotional). Dialysis adequacy, as measured by Kt/V, was a poor correlate for Short Form 36 scores. Similarly, mineral metabolism (e.g., calcium x phosphorous, parathyroid hormone) and inflammatory (e.g., C-reactive protein, TNF) biomarkers had small effect sizes and correlations with HRQOL. In contrast, hematocrit demonstrated small to moderate relationships with mental and physical HRQOL, and nutritional biomarkers (e.g., albumin, creatinine, body mass index) demonstrated moderate to large relationships. CONCLUSIONS: HRQOL in ESRD is most affected in the physical domains, and nutritional biomarkers are most closely associated with these domains. In contrast, Kt/V, mineral metabolism indices, and inflammatory markers are poor HRQOL correlates.
Authors: P Rebollo; F Ortega; J M Baltar; X Badía; F Alvarez-Ude; C Díaz-Corte; M Naves; R A Navascúes; A Ureña; J Alvarez-Grande Journal: Clin Transplant Date: 2000-06 Impact factor: 2.863
Authors: Kamyar Kalantar-Zadeh; Noriko Kuwae; Dennis Y Wu; Ronney S Shantouf; Denis Fouque; Stefan D Anker; Gladys Block; Joel D Kopple Journal: Am J Clin Nutr Date: 2006-02 Impact factor: 7.045
Authors: Kristina L Allen; Dana Miskulin; Guofen Yan; Johanna T Dwyer; Anne Frydrych; June Leung; Diane Poole Journal: J Ren Nutr Date: 2002-07 Impact factor: 3.655
Authors: Aaron S Yarlas; Michelle K White; Min Yang; Renee N Saris-Baglama; Peter Galthen Bech; Torsten Christensen Journal: Qual Life Res Date: 2010-10-23 Impact factor: 4.147
Authors: Ewa Baum; Krzysztof Pawlaczyk; Beata Maćkowiak; Patrycja Sosinska; Monika Matecka; Barbara Kolodziejczak; Michał Musielak; Andrzej Breborowicz Journal: Int J Clin Exp Pathol Date: 2015-10-01
Authors: Ramony Chan; Robert Brooks; Zachary Steel; Tracy Heung; Jonathan Erlich; Josephine Chow; Michael Suranyi Journal: Qual Life Res Date: 2011-07-31 Impact factor: 4.147
Authors: Eduardo Lacson; Jianglin Xu; Shu-Fang Lin; Sandie Guerra Dean; J Michael Lazarus; Raymond M Hakim Journal: Clin J Am Soc Nephrol Date: 2009-12-17 Impact factor: 8.237
Authors: Ezra Gabbay; Klemens B Meyer; John L Griffith; Michelle M Richardson; Dana C Miskulin Journal: Clin J Am Soc Nephrol Date: 2009-12-17 Impact factor: 8.237